PMC:7560789 / 452-551 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":80,"end":89},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"y (preemptive) treatment of IPA are recommended in critically ill patients with influenza (2). In I"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":28,"end":31},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_17824"},{"id":"A7","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_30802"}],"text":"y (preemptive) treatment of IPA are recommended in critically ill patients with influenza (2). In I"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":28,"end":31},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0020103"}],"text":"y (preemptive) treatment of IPA are recommended in critically ill patients with influenza (2). In I"}

{"project":"LitCovid-PubTator","denotations":[{"id":"43","span":{"begin":66,"end":74},"obj":"Species"},{"id":"66","span":{"begin":51,"end":65},"obj":"Disease"}],"attributes":[{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"Tax:9606"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"y (preemptive) treatment of IPA are recommended in critically ill patients with influenza (2). In I"}